AIRS
NASDAQ
$4.78
Airsculpt Technologies Inc (AIRS)
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, specializing in its proprietary AirSculpt® procedure, which sets a new standard for minimally invasive body contouring while prioritizing patient safety and comfort. The company is aggressively expanding its network of licensed practitioners and utilizing innovative technologies to solidify its competitive advantage in the rapidly growing non-invasive cosmetic treatment market. With rising global demand for aesthetic solutions, Airsculpt is well-positioned to capture market share and broaden its service offerings, driving robust growth and long-term value for its investors.
Sector:
Healthcare
Industry:
Medical Care Facilities
Hold
Target: $4.50 (-5.86%)
Market Cap
$293M
Free Cash Flow Yield
2.37%
Beta (5Y)
2.27
Price Chart
Valuation
Market Cap$293M
P/S1.88
P/B2.94
Profitability
Total Revenue (TTM)$152M
Gross Profit (TTM)$100M
EBITDA$787K
Profit Margin-6.1%
Operating Margin-4.6%
EPS-$0.18
Financial Health
Debt-to-Equity44.7%
Free Cash Flow Yield2.37%
Growth & Risk
Beta (5Y)2.27
Sharpe Ratio0.39